All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the International Myeloma Foundation or Myeloma crowd.
During the 63rd ASH Annual Meeting and Exposition, the Multiple Myeloma Hub was pleased to speak to Timothy M. Schmidt, University of Wisconsin-Madison, Madison, US. We asked, why should chromosome 1 abnormalities be assessed in all patients with multiple myeloma (MM)?
Why should chromosome 1 abnormalities be assessed in all patients with MM?
In this video, Schmidt discusses the importance and utility of assessing chromosome 1 abnormalities for prognosis of high-risk MM patients. He also highlights the importance of identifying patients with chromosomal abnormalities early.
Prof. Nikhil Munshi | ASH 2017 | Genomic landscape of MM
59th ASH Annual Meeting and Exposition, 9 - 12 Dec 2017, Atlanta, GA Professor Nikhil Munshi Dana-Farber Cancer Institute, Boston, US Interview title: Genomic landscape of MM
ASH 2021 abstracts: What’s hot in multiple myeloma?
To help navigate the exciting content being presented at the 63rd ASH Annual Meeting and Exposition, the Multiple Myeloma Hub Steering Committee members have provided their recommendations for the...
Subscribe to get the best content related to multiple myeloma delivered to your inbox